CLDN22 Serves as a Novel Prognostic Biomarker and Immunotherapy Response Predictor in Gliomas: A Comprehensive Multiomics Analysis.
- DOI
- 10.1155/ijog/9367254
- Published
- 2025
- Container
- International journal of genomics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1155/ijog/9367254,
title = {CLDN22 Serves as a Novel Prognostic Biomarker and Immunotherapy Response Predictor in Gliomas: A Comprehensive Multiomics Analysis.},
author = {Zheng H and Cheng J and Liu J and Liu G and Dang R and Luo R and Lou J},
year = {2025},
journal = {International journal of genomics},
doi = {10.1155/ijog/9367254},
url = {https://doi.org/10.1155/ijog/9367254}
}RIS
TY - JOUR TI - CLDN22 Serves as a Novel Prognostic Biomarker and Immunotherapy Response Predictor in Gliomas: A Comprehensive Multiomics Analysis. AU - Zheng H AU - Cheng J AU - Liu J AU - Liu G AU - Dang R AU - Luo R AU - Lou J PY - 2025 JO - International journal of genomics DO - 10.1155/ijog/9367254 UR - https://doi.org/10.1155/ijog/9367254 ER -
APA
H, Z., J, C., J, L., G, L., R, D., R, L., & J, L. (2025). CLDN22 Serves as a Novel Prognostic Biomarker and Immunotherapy Response Predictor in Gliomas: A Comprehensive Multiomics Analysis.. International journal of genomics. https://doi.org/10.1155/ijog/9367254
Source records
- pubmed · retrieved 2026-09-26T10:54:06.580Z
- europe-pmc · retrieved 2026-09-26T10:54:06.594Z
- doaj · retrieved 2026-09-26T10:54:06.578Z